Skip to main content
logo
Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
11.21
+0.06 (0.54%)
At close: Mar 20, 2026, 4:00 PM EDT
11.43
+0.22 (1.96%)
After-hours: Mar 20, 2026, 7:42 PM EDT

Phathom Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
8831,185556529465600
Market Cap Growth
115.00%112.96%5.12%13.75%-22.47%-36.65%
Enterprise Value
1,3431,266460.51286.18406.26507.75
Last Close Price
11.2116.598.129.1311.2219.67
PE Ratio
--5.48-1.53-2.32-2.22-5.06
PS Ratio
5.046.7710.07776.05--
PB Ratio
--2.70-2.19-7.27-6.228.32
P/TBV Ratio
-1.87-2.76-2.02-6.44-5.8710.09
P/FCF Ratio
--7.09-2.08-3.80-3.15-4.03
P/OCF Ratio
--7.10-2.09-3.85-3.18-4.04
EV/Sales Ratio
7.677.238.33419.61--
EV/EBITDA Ratio
--7.94-1.66-1.72-2.36-3.77
EV/EBIT Ratio
--7.91-1.66-1.71-2.36-3.76
EV/FCF Ratio
--7.58-1.73-2.06-2.75-3.41
Debt / Equity Ratio
-0.48-0.48-0.79-1.90-1.291.26
Debt / EBITDA Ratio
-1.33-1.33-0.73-0.83-0.56-0.68
Debt / FCF Ratio
-1.27-1.27-0.76-1.00-0.66-0.61
Net Debt / Equity Ratio
-0.19-0.190.383.330.78-1.27
Net Debt / EBITDA Ratio
-0.51-0.510.351.450.340.68
Net Debt / FCF Ratio
-0.49-0.490.361.740.400.62
Asset Turnover
0.550.550.140.0000
Inventory Turnover
5.185.183.610.28--
Quick Ratio
1.581.583.929.885.929.69
Current Ratio
1.731.734.2010.256.129.86
Return on Equity (ROE)
63.97%63.97%204.89%273.21%14877.58%-108.01%
Return on Assets (ROA)
-50.19%-50.19%-70.05%-57.83%-97.36%-55.76%
Return on Invested Capital (ROIC)
-664.74%-664.74%-3243.33%2292.10%1215.82%516.12%
Return on Capital Employed (ROCE)
-76.24%-76.24%-83.12%-65.15%-111.58%-65.88%
Earnings Yield
-25.05%-18.26%-65.15%-43.04%-45.01%-19.78%
FCF Yield
-18.91%-14.10%-47.97%-26.30%-31.72%-24.79%
Buyback Yield / Dilution
0.02%0.02%-22.17%-29.40%-5.29%-0.32%
Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q